scholarly journals Effect of the patient information brochure in communicating the risks associated with crizotinib treatment to patients with non‐small cell lung cancer (NSCLC) in Europe

2020 ◽  
Vol 8 (2) ◽  
Author(s):  
Kui Huang ◽  
Terri Madison ◽  
Beatrice Wehler ◽  
Marcello Tiseo ◽  
Keith D. Wilner ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Patient Information ◽  
Small Cell ◽  
Small Cell Lung ◽  
Information Brochure

Small cell lung cancer

2001 ◽  
Vol 37 ◽  
pp. 61-63
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

Non-small cell lung cancer

2001 ◽  
Vol 37 ◽  
pp. 47-61
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

EGFR Mutation and Resistance of Non-Small-Cell Lung Cancer to Gefitinib

2006 ◽  
Vol 2006 ◽  
pp. 228-229
Author(s):  
N.H. Hanna
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Egfr Mutation ◽  
Small Cell ◽  
Small Cell Lung

Abstract #829: Effect of Body Mass Index (BMI) and Lipids on Non-Small Cell Lung Cancer (NSCLC) Survival

2016 ◽  
Vol 22 ◽  
pp. 176
Author(s):  
Genevieve Streb ◽  
Narjust Duma ◽  
Natasha Piracha ◽  
Sejal Kothadia ◽  
Komal Patel ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Body Mass Index ◽  
Small Cell Lung Cancer ◽  
Body Mass ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung

Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

2009 ◽  
pp. 1-1
Author(s):  
A. R. Jazieh ◽  
R. Komrokji ◽  
A. Gupta ◽  
S. Patil ◽  
D. Flora ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document